SR biotek Inc. (XKON:270210)
South Korea
· Delayed Price · Currency is KRW
32,350
+250 (0.78%)
At close: Mar 9, 2026
SR biotek Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2016 | FY 2015 |
| Mar '26 Mar 6, 2026 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
| Debt / Equity Ratio | 3.15 | 3.15 | 2.95 |
| Debt / EBITDA Ratio | 5.69 | 5.69 | 2.82 |
| Debt / FCF Ratio | 76.38 | 76.38 | - |
| Net Debt / Equity Ratio | 2.49 | 2.49 | 2.21 |
| Net Debt / EBITDA Ratio | 4.50 | 4.50 | 2.11 |
| Net Debt / FCF Ratio | 60.36 | 60.36 | -0.89 |
| Asset Turnover | 0.61 | 0.61 | - |
| Inventory Turnover | 2.98 | 2.98 | - |
| Quick Ratio | 0.45 | 0.45 | 0.72 |
| Current Ratio | 0.78 | 0.78 | 1.26 |
| Return on Equity (ROE) | -13.21% | -13.21% | - |
| Return on Assets (ROA) | 1.20% | 1.20% | - |
| Return on Invested Capital (ROIC) | 2.65% | 2.65% | 22.68% |
| Return on Capital Employed (ROCE) | 3.10% | 3.10% | 21.30% |
| Buyback Yield / Dilution | - | -0.02% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.